Calvin Gilkey, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 130 Fisher Rd Unit 1, Berlin, VT 05602 Phone: 802-371-4100 |
Dr. Benjamin P Parkhurst, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1311 Route 302 Ste 4, Berlin, VT 05602 Phone: 802-225-3970 |
Dr. Donald N Weinberg, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 130 Fisher Rd, Hospitalist, Berlin, VT 05602 Phone: 802-225-1743 Fax: 802-225-1745 |
News Archive
Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, today announced that the Instituto de Salud Publica of Chile has approved the Company's protocol for its Phase 2 clinical study of TI-001, intranasal oxytocin, for the treatment of chronic migraine.
Alchemia's subsidiary Alchemia Oncology today presented two posters at the American Association of Cancer Research (AACR) 101st Annual Meeting in Washington, DC. The data demonstrates the ability of the Company's HyACT tumour targeting technology to dramatically enhance the killing of cancer stem cells. These cells are highly resistant to treatment with chemotherapeutic drugs and are believed to be responsible for treatment failure and disease recurrence.
The Society of Toxicology (SOT) 51st Annual Meeting and ToxExpo - the largest meeting and expo of its kind anywhere in the world - will take place from March 11-15. The five-day program will feature more than 180 sessions, presenting the latest research findings and recommendations for remedial action on a wide range of issues affecting human and animal health and the environment.
In recent years, scientists have introduced us to a paradigm shift in the microscopic world. We've moved from thinking about all bacteria as bad guys to be wiped out with antibiotics and hand sanitizer to recognizing that some microbes are helpers, good bacteria that live in our GI tract (and all over our bodies) that keep us healthy.
› Verified 5 days ago